Titre :
  • Phase III trial comparing two dose levels of epirubicin combined with cyclophosphamide with cyclophosphamide, methotrexate, and fluorouracil in node-positive breast cancer.
Auteur : Piccart-Gebhart, Martine ; Di Leo, Angelo ; Beauduin, Marc ; Vindevoghel, Anita ; Michel, Jeffrey ; Focan, Christian ; Tagnon, Alain ; Ries, Fernand ; Gobert, P ; Finet, Claude ; Closon-Dejardin, Marie Thérèse ; Dufrane, J P ; Kerger, Joseph ; Liebens, Fabienne ; Beauvois, Sylvie ; Bartholomeus, Sylvie ; Dolci, Stella ; Lobelle, Jean Pierre ; Paesmans, Marianne ; Nogaret, Jean-Marie
Informations sur la publication : Journal of clinical oncology, 19, 12, (page 3103-3110)
Statut de publication : Publié, 2001-06
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés MeSH : Adult
Aged
Antineoplastic Combined Chemotherapy Protocols -- adverse effects
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
Belgium -- epidemiology
Breast Neoplasms -- drug therapy
Breast Neoplasms -- mortality
Breast Neoplasms -- pathology
Chemotherapy, Adjuvant -- methods
Cyclophosphamide -- administration & dosage
Disease-Free Survival
Dose-Response Relationship, Drug
Epirubicin -- administration & dosage
Female
Fluorouracil -- administration & dosage
Humans
Methotrexate -- administration & dosage
Middle Aged
Prognosis
Proportional Hazards Models
Statistics, Nonparametric
Survival Rate
Note : Clinical Trial
Clinical Trial, Phase III
Comparative Study
Journal Article
Multicenter Study
Randomized Controlled Trial
Langue :
  • Anglais
Identificateurs : urn:issn:0732-183X 
info:pmid/11408507